Stanford

The Ludwig Center at Stanford University is dedicated to investigating cancer and its treatment from the perspective of stem-cell biology and medicine.

About

Researchers at Ludwig Stanford work in a variety of fields of vital importance to cancer care, ranging from immunology and genomics to studies of blood-generating stem cells and the tumor microenvironment. The basic and applied research conducted in our laboratories contributes to the development of everything from novel immunotherapies and stem cell-based strategies for cancer treatment to advanced cancer diagnostics.

The Ludwig Center is housed within the Stanford University School of Medicine.

DIRECTOR

Irving Weissman
Tumor immunology
Dartmouth College, Hanover, New Hampshire
BS, Montana State University, Bozeman, Montana
MD, Stanford University

Principal Investigators

Ash Alizadeh
Cancer genomics
Laura Attardi
Tumor biology
Philip Arden Beachy
Tumor biology
Howard Chang
Cancer genomics
Michael F. Clarke
Tumor biology
Agnieszka Czechowicz
Cancer prevention
Tushar Desai
Tumor biology, Tumor microenvironment
Maximilian Diehn
Cancer genomics, Tumor biology
Kenan C. Garcia
Tumor biology
Sidd Jaiswal
Cancer genomics, Cancer prevention
Peter S. Kim
Tumor immunology
Calvin J. Kuo
Tumor biology, Tumor immunology
Ronald Levy
Tumor immunology, Tumor microenvironment
Kyle M. Loh
Tumor biology
Crystal L. Mackall
Tumor biology
Ravi Majeti
Tumor biology, Tumor immunology
Michelle Monje
Tumor biology, Tumor microenvironment
Hiromitsu Nakauchi
Tumor biology
Aaron M. Newman
Cancer genomics, Tumor biology
Roeland Nusse
Tumor biology
Maria Grazia Roncarolo
Cancer prevention, Tumor immunology
Julien Sage
Cancer genomics, Tumor biology
Lucy Shapiro
Tumor biology, Tumor microenvironment
Judith Shizuru
Tumor biology
Matt Van de Rijn
Tumor biology
Gerlinde Wernig
Cancer genomics, Tumor microenvironment
Joanna Wysocka
Tumor biology

Highlights

The stem cell pioneer
The consummate neuro-oncologist
The dark genome’s explorer
Science in the blood: Q&A with Ravi Majeti
Women in Science: Crystal Mackall
The inspired neuro-oncologist: Q&A with Michelle Monje
The quintessential imager
The transplant sorcerer
DNA detectives
Stanford stem-cell researchers
Serving up cancer cells
Idea man: Q&A with Irv Weissman

News

A possible strategy for immune system rejuvenation
September 11, 2024
Making peace between two promising strategies for immunotherapy
September 11, 2024
The risk of secondary cancers caused by CAR-T cell engineering found to be relatively low
September 11, 2024
An alternative driver of SCLC metastasis illustrates the cancer’s plasticity
April 25, 2024
Finding the oncogenic culprit in amplified chromosomal segments that drive cancer
April 25, 2024
Study suggests co-targeting of G-MDSCs and macrophages to treat melanoma
April 25, 2024
An RNA-editing platform, used for metabolic engineering, boosts CAR-T performance
April 25, 2024
Five Ludwig Cancer Research scientists were elected Fellows of the AACR
April 25, 2024
A polymorphism in a promoter explains a mystery of the blood
November 28, 2023
The KRAS oncogene generates a stem cell to spawn an indolent lung cancer
November 27, 2023
A high-res protein structure yields a blueprint for precision drug design
November 27, 2023
Cell free DNA analysis reveals determinants of failure of CAR-T cell therapy for LBCL
June 28, 2023
Study shows cancer cells can be reprogrammed into living cancer vaccines
June 28, 2023
Mutations that could serve as prognostic markers of follicular lymphoma
June 28, 2023
New method sharpens picture of how cellular location influences patterns of gene expression
June 28, 2023
Two panel discussions enriched the Ludwig community’s ongoing conversation on women in science
June 28, 2023
An oncogene expressed by a minority of breast cancer cells drives metastasis
January 31, 2023
Analysis of tumor fibroblast sub-populations reveals new strategies for cancer therapy
January 31, 2023
Three Ludwig researchers elected to the National Academy of Medicine
January 31, 2023
Ludwig Stanford study solves long-sought protein structure, shows how mutation drives blood cancers
March 10, 2022
Ludwig Stanford study devises method to predict who may benefit from CAR-T cell therapy for blood cancers
July 26, 2021
Ludwig Stanford study shows anti-CD47 antibody therapy could improve efficacy of HER2+ breast cancer treatment
July 20, 2021
Ludwig Cancer Research mourns the death of Sanjiv Sam Gambhir
July 20, 2020
A single number to mark the deadliest cancer cells
January 29, 2020
Ludwig researchers engineer CAR-T cells to resist exhaustion, attack solid tumors in mice
December 10, 2019
Aggressive brain cancers tap into neural wiring to thrive
September 27, 2019
New ‘don’t eat me’ signal may provide basis for cancer therapies
July 31, 2019
Ludwig Stanford researchers borrow from sports playbook to predict cancer outcomes
July 9, 2019
New computational tool enables powerful molecular analysis of biomedical tissue samples
May 7, 2019
Modified immune cells issue alert when detecting cancer in mice
March 19, 2019
Antibody could increase cure rate for blood, immune disorders
February 15, 2019
Ludwig Stanford researchers devise urine test for bladder cancer
January 29, 2019
‘Chemo brain’ caused by malfunction in three types of brain cells
December 13, 2018
Study led by Ludwig Stanford researcher maps accessible cancer genome across 23 types of cancer
November 1, 2018
Liquid biopsy predicts Lymphoma therapy success within days
August 24, 2018
Engineered T cell therapy clears incurable childhood brain tumor in mice
April 20, 2018
Ludwig Stanford Professor Howard Chang honored with NAS award in molecular biology
January 17, 2018
Ludwig Stanford researchers discover second “don’t eat me” signal on cancer cells
November 27, 2017
Ludwig researchers find breakthrough cancer therapy may work in an unexpected way
May 17, 2017
Ludwig Stanford researchers show ‘don’t eat me’ antibody could help treat pediatric brain tumors
March 20, 2017
New technique reveals movements of immune cells as they hunt for tumors in living patients
January 23, 2017
Coaxing leukemia cells into an embryonic state
January 12, 2017
Blood test could provide cheaper, better way for doctors to manage lung cancer
December 15, 2016
New immunotherapy possible for canine cancer
November 15, 2016
Ludwig researchers find withholding an amino acid from diet depletes blood stem cells
October 20, 2016
A safer way for bone marrow transplants
August 10, 2016
A big step toward regenerative medicine
July 14, 2016
Toward a liquid biopsy
March 28, 2016
A marker for the true blood stem cell
February 10, 2016
Chemotherapy after surgery may benefit an identifiable subgroup of stage-2 colon cancer patients
January 20, 2016
Reconstructing a smoothie
March 31, 2015
Dialing a bespoke signal
March 16, 2015
Peter S. Kim named the Virginia and D.K. Ludwig Professor of Biochemistry at Stanford
January 13, 2015
Ludwig researchers target two types of pancreatic cancer
May 20, 2014
Blood test could provide rapid, accurate method of detecting solid cancers, a study from the Ludwig Center at Stanford finds
April 6, 2014
Ludwig scientists at Stanford University unable to find evidence of “embryonic-like” cells in marrow of adult mice
July 24, 2013
Anti-CD47 antibody may offer new route to a successful cancer vaccination
May 31, 2013
Engineered molecules boost immune attack on cancer
May 31, 2013
Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests, Stanford researchers say
February 5, 2013
Single antibody shrinks variety of human tumors transplanted into mice, study by Ludwig Center Director Irv Weissman shows
March 27, 2012
Stanford computer algorithm used to identify bladder cancer marker
January 18, 2012
More News
   Back to Locations

Ludwig Center at Stanford
Lokey Stem Cell Research Building
265 Campus Dr., 3rd Floor
Stanford, California, U.S. 94305-5323

T 650 234 0675

Stay In Touch

Notice
?

You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

Continue
Cancel